C World Wide Group Holding A Coherus Bio Sciences, Inc. Transaction History
C World Wide Group Holding A
- $8.2 Billion
- Q4 2024
A detailed history of C World Wide Group Holding A transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, C World Wide Group Holding A holds 1,928,464 shares of CHRS stock, worth $2.12 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,928,464
Previous 1,928,464
-0.0%
Holding current value
$2.12 Million
Previous $2.01 Million
32.65%
% of portfolio
0.03%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding CHRS
# of Institutions
130Shares Held
67.8MCall Options Held
1.68MPut Options Held
91.8K-
Black Rock Inc. New York, NY11.8MShares$12.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.2MShares$12.3 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.28MShares$5.81 Million0.02% of portfolio
-
Rubric Capital Management LP New York, NY5.26MShares$5.78 Million0.12% of portfolio
-
Tang Capital Management LLC San Diego, CA3.65MShares$4.02 Million0.38% of portfolio
About Coherus BioSciences, Inc.
- Ticker CHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,724,600
- Market Cap $85.5M
- Description
- Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...